No abstract available
Keywords:
ANZSCTS; Australia; COVID-19; CSANZ; Cardiomyopathy; Cardiovascular disease; Myocarditis; Pericarditis; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); mRNA vaccine.
MeSH terms
-
COVID-19 Vaccines
-
COVID-19*
-
Cardiomyopathies* / diagnosis
-
Cardiomyopathies* / etiology
-
Humans
-
Myocarditis* / diagnosis
-
Myocarditis* / etiology
-
Pericarditis* / diagnosis
-
Pericarditis* / etiology
-
SARS-CoV-2
-
Vaccination / adverse effects